Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 237

1.

The new melanoma staging system.

Kim CJ, Reintgen DS, Balch CM; AJCC Melanoma Staging Committee.

Cancer Control. 2002 Jan-Feb;9(1):9-15. Review.

PMID:
11907461
2.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.

Ann Surg Oncol. 2003 Jun;10(5):569-74.

PMID:
12794025
3.

The revised American Joint Committee on Cancer staging system for melanoma.

Thompson JA.

Semin Oncol. 2002 Aug;29(4):361-9.

PMID:
12170439
4.

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C.

J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. Review. German.

PMID:
16033477
5.

A new American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton A Jr, Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM.

Cancer. 2000 Mar 15;88(6):1484-91.

PMID:
10717634
6.

New TNM melanoma staging system: linking biology and natural history to clinical outcomes.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

Semin Surg Oncol. 2003;21(1):43-52. Review.

PMID:
12923915
7.

Sentinel node biopsy provides more accurate staging than elective lymph node dissection in patients with cutaneous melanoma.

Doubrovsky A, De Wilt JH, Scolyer RA, McCarthy WH, Thompson JF.

Ann Surg Oncol. 2004 Sep;11(9):829-36. Epub 2004 Aug 16.

PMID:
15313732
8.

The new staging system for cutaneous melanoma in the era of lymphatic mapping.

Rousseau DL Jr, Gershenwald JE.

Semin Oncol. 2004 Jun;31(3):415-25. Review.

PMID:
15190500
9.

An evidence-based staging system for cutaneous melanoma.

Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

CA Cancer J Clin. 2004 May-Jun;54(3):131-49; quiz 182-4. Review.

10.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

J Clin Oncol. 2001 Aug 15;19(16):3635-48. Review.

PMID:
11504745
11.
12.

Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.

Balch CM, Soong SJ, Gershenwald JE, Thompson JF, Reintgen DS, Cascinelli N, Urist M, McMasters KM, Ross MI, Kirkwood JM, Atkins MB, Thompson JA, Coit DG, Byrd D, Desmond R, Zhang Y, Liu PY, Lyman GH, Morabito A.

J Clin Oncol. 2001 Aug 15;19(16):3622-34.

PMID:
11504744
13.

Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, Alastrué A, Ferrándiz C.

Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93.

PMID:
16416605
14.

Prediction of metastatic melanoma in nonsentinel nodes and clinical outcome based on the primary melanoma and the sentinel node.

Cochran AJ, Wen DR, Huang RR, Wang HJ, Elashoff R, Morton DL.

Mod Pathol. 2004 Jul;17(7):747-55.

15.

Surgical management of the groin lymph nodes in melanoma in the era of sentinel lymph node dissection.

Essner R, Scheri R, Kavanagh M, Torisu-Itakura H, Wanek LA, Morton DL.

Arch Surg. 2006 Sep;141(9):877-82; discussion 882-4.

PMID:
16983031
16.

Review of the 2001 AJCC staging system for cutaneous malignant melanoma.

Schuchter LM.

Curr Oncol Rep. 2001 Jul;3(4):332-7. Review.

PMID:
11389818
17.

Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?

Nahabedian MY, Tufaro AP, Manson PN.

Ann Plast Surg. 2003 Jun;50(6):601-6.

PMID:
12783009
18.

American Joint Committee on Cancer clinical stage as a selection criterion for sentinel lymph node biopsy in thin melanoma.

Vaquerano J, Kraybill WG, Driscoll DL, Cheney R, Kane JM 3rd.

Ann Surg Oncol. 2006 Feb;13(2):198-204. Epub 2006 Jan 19.

PMID:
16418885
19.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
20.

Our experience of melanoma thickness as a predictor of outcome of sentinel node biopsy.

Homolak D, Vucetić B, Puljiz Z, Blajć I, Vurnek Zivković M, Situm M.

Coll Antropol. 2008 Oct;32 Suppl 2:57-60.

PMID:
19138008
Items per page

Supplemental Content

Write to the Help Desk